Milltown, NJ, United States of America

Carl F Anderson



Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Milltown, NJ (US) (1987)
  • North Brunswick, NJ (US) (1989)

Company Filing History:


Years Active: 1987-1989

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Carl F Anderson

Introduction

Carl F Anderson is a notable inventor based in Milltown, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Anderson's work has had a meaningful impact on medical science.

Latest Patents

Anderson's latest patents include the "Delta form of aztreonam and preparation thereof." This patent describes the crystalline delta (.delta.)-form of a specific compound, which is crucial for developing new therapeutic agents. Another significant patent is the "Copper-mediated oximation reaction," which details the use of a copper salt in the oximation of a beta-lactam compound. These inventions showcase his expertise in chemical processes and their applications in medicine.

Career Highlights

Throughout his career, Anderson has been associated with E.R. Squibb & Sons, Inc., a company known for its commitment to pharmaceutical innovation. His work at this esteemed organization has allowed him to focus on developing new compounds that can lead to better treatment options for patients.

Collaborations

Anderson has collaborated with several talented individuals in his field, including Neal G Anderson and Thomas C Sedergran. These partnerships have likely contributed to the success of his inventions and the advancement of pharmaceutical research.

Conclusion

Carl F Anderson's contributions to the field of pharmaceuticals through his patents reflect his dedication to innovation and improving healthcare. His work continues to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…